CN101843817B - Chinese medicament for treating chronic hepatitis - Google Patents

Chinese medicament for treating chronic hepatitis Download PDF

Info

Publication number
CN101843817B
CN101843817B CN2009102371062A CN200910237106A CN101843817B CN 101843817 B CN101843817 B CN 101843817B CN 2009102371062 A CN2009102371062 A CN 2009102371062A CN 200910237106 A CN200910237106 A CN 200910237106A CN 101843817 B CN101843817 B CN 101843817B
Authority
CN
China
Prior art keywords
chinese
parts
chinese medicine
chronic hepatitis
radix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2009102371062A
Other languages
Chinese (zh)
Other versions
CN101843817A (en
Inventor
刘新壮
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
An Xiaoling
Original Assignee
Lvyuan Qiuzheng Technology Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lvyuan Qiuzheng Technology Development Co Ltd filed Critical Lvyuan Qiuzheng Technology Development Co Ltd
Priority to CN2009102371062A priority Critical patent/CN101843817B/en
Publication of CN101843817A publication Critical patent/CN101843817A/en
Application granted granted Critical
Publication of CN101843817B publication Critical patent/CN101843817B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a Chinese medicament for treating chronic hepatitis, and belongs to the field of Chinese medicaments for treating digestive system diseases. The invention aims to provide the Chinese medicament with good effect and quick response. The Chinese medicament is prepared from the following raw materials: giant knotweed, radix pseudo-ginseng, lucid ganoderma, Japanese ardisia, stringy stonecrop herb, glabrous greenbrier rhizome, Chinese angelica, root of rehmannia and the like. The Chinese medicament has the effects of strengthening body resistance and banking up root, tonifying qi and nourishing blood, activating blood and dissolving stasis, and clearing heat, promoting diuresis, and detoxicating, and has the advantages of obvious effect, exact medicinal effect and quick response.

Description

A kind of Chinese medicine for the treatment of chronic hepatitis
Technical field
The invention belongs to the field of Chinese medicines of treatment digestive system disease.
Background technology
The present field of Chinese medicines that is intended to treat chronic hepatitis, the deficiency of two aspects of existence: the one, effect is obvious inadequately, and the 2nd, it is slower to take effect.So that large quantities of chronic hepatitis patients are because of can not get the treatment of active drug, liver disease constantly develops, and clinical symptoms can not get alleviating, and the patient is seriously weak for a long time, dull pain in liver, liver function descend, hepatic fibrosis is serious etc., patient's life quality descends, and I and family members are dissatisfied to this.
At problem set forth above, the invention provides a kind of Chinese medicine for the treatment of chronic hepatitis, it is obvious inadequately that it can solve in this type of treatment by Chinese herbs in the past effect, the slower problem that takes effect, effective, instant effect, it is remarkable to have effect, drug effect is definite, the advantage of quick result.
Summary of the invention
The present invention is achieved through the following technical solutions:
1, a kind of Chinese medicine for the treatment of chronic hepatitis adopts the raw material of Chinese medicine preparation, and filling a prescription is (by weight):
Rhizoma Polygoni Cuspidati 4-30 part Radix Notoginseng 3-20 part Ganoderma 2-15 part
PINGDIMU 4-30 part Herba Sedi 5-40 part Rhizoma Smilacis Glabrae 4-30 part
Radix Angelicae Sinensis 4-30 part Radix Rehmanniae 4-30 part
The Chinese medicine of this treatment chronic hepatitis is made by following method:
(1) by above-mentioned weight ratio, Rhizoma Polygoni Cuspidati, PINGDIMU, Herba Sedi, Rhizoma Smilacis Glabrae, Radix Angelicae Sinensis, the Radix Rehmanniae are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Radix Notoginseng, Ganoderma are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; As required, can be made into Chinese medicine electuary, granule, powder, capsule, watered pill, tablets and other formulations.
The present invention is according to the folk tradition prescription, and the theory according to traditional Chinese medical science the body resistance strengthening and constitution consolidating, blood circulation promoting and blood stasis dispelling develops meticulously.Ganoderma, Radix Rehmanniae the body resistance strengthening and constitution consolidating, benefiting QI and nourishing blood in the side; Radix Angelicae Sinensis, pseudo-ginseng blood-circulation-invigovating blood stasis dispelling; Be aided with Rhizoma Polygoni Cuspidati, PINGDIMU clearing away heat-damp and promoting diuresis, go into the blood detoxifcation; Enzyme falls in Herba Sedi, the detoxifcation of Rhizoma Smilacis Glabrae clearing away heat-damp and promoting diuresis.All medicine compatibilities bring out the best in each other, and play the body resistance strengthening and constitution consolidating altogether, benefiting QI and nourishing blood, and blood circulation promoting and blood stasis dispelling, the merit of clearing away heat-damp and promoting diuresis detoxifcation, effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
The specific embodiment
By following embodiment the present invention is done and to specify:
1, get following prescription (weight is unit by gram):
Rhizoma Polygoni Cuspidati 60 gram Radix Notoginseng 40 kairine sesames 30 grams
PINGDIMU 60 gram Herba Sedis 70 gram Rhizoma Smilacis Glabraes 50 grams
The Radix Angelicae Sinensis 50 gram Radix Rehmanniae 50 grams
Weight in accordance with regulations, with conventional water extraction process Rhizoma Polygoni Cuspidati, PINGDIMU, Herba Sedi, Rhizoma Smilacis Glabrae, Radix Angelicae Sinensis, the Radix Rehmanniae are extracted, make extractum fine powder 102 grams, Radix Notoginseng, Ganoderma are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder, make fine particle, the capsule of packing into No. 0 is made 614 of Chinese medicinal capsules, and every capsules includes Chinese medicine fine powder and extract 0.28 gram.
2, get following prescription (weight is unit by gram):
Rhizoma Polygoni Cuspidati 160 gram Radix Notoginseng 120 kairine sesames 90 grams
PINGDIMU 160 gram Herba Sedis 220 gram Rhizoma Smilacis Glabraes 160 grams
The Radix Angelicae Sinensis 180 gram Radix Rehmanniae 180 grams
By above-mentioned same method, make 1886 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
3, get following prescription (weight is unit by gram):
Rhizoma Polygoni Cuspidati 300 gram Radix Notoginseng 200 kairine sesames 150 grams
PINGDIMU 300 gram Herba Sedis 400 gram Rhizoma Smilacis Glabraes 300 grams
The Radix Angelicae Sinensis 300 gram Radix Rehmanniae 300 grams
By above-mentioned same method, make 3286 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
4, get following prescription (by weight):
3 parts of 4 portions of Ganodermas of 5 portions of Radix Notoginseng of Rhizoma Polygoni Cuspidati
5 parts of 7 parts of Rhizoma Smilacis Glabraes of 5 portions of Herba Sedis of PINGDIMU
5 parts in 5 parts of Radix Rehmanniae of Radix Angelicae Sinensis
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
5, get following prescription (by weight):
12 parts of 15 portions of Ganodermas of 20 portions of Radix Notoginseng of Rhizoma Polygoni Cuspidati
20 parts of 30 parts of Rhizoma Smilacis Glabraes of 20 portions of Herba Sedis of PINGDIMU
18 parts in 18 parts of Radix Rehmanniae of Radix Angelicae Sinensis
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
Clinical data:
The present invention is an example with traditional Chinese medical science chronic hepatitis, through 17 routine clinical observations.Selecting the tcm diagnosis chronic hepatitis is standard: limb is soft weak, and is weak from head to foot; Poor appetite, abdominal distention, dyspepsia; Face is pitch-dark, hepatic face is arranged; Dull pain in liver; Hepatic fibrosis is serious; It is undesired that liver function transaminase continues, and other index such as plasma albumin, blood total bilirubin etc. are defective.As above symptom can be made a definite diagnosis.In making a definite diagnosis the object of observation, male's 10 examples, women's 7 examples do not have other serious disease, and the age is 49 years old-78 years old, 62.2 years old mean age.
Efficacy determination:
1, produce effects: weak alleviation, on one's body energetically; Poor appetite, abdominal distention, dull pain in liver are alleviated, and the hepatic region is comfortable; Hepatic face is taken on a new look to some extent, and it is pale that face becomes; The hepatic fibrosis inspection is alleviated obviously; Indexs such as liver function test transaminase, plasma albumin are obviously improved.
2, effective: weak solution, on one's body energetically, abdominal distention, poor appetite, hepatic face are alleviated to some extent.
3, invalid: the disease no change.
During clinical experiment, withdraw other medicines and health nutrient.Taking Chinese medicinal capsule of the present invention, observed 3 months, is a course of treatment.Instructions of taking: every day 3 times, each 5 capsules, every capsules include Chinese medicine fine powder and extract 0.28 gram, warm water delivery service after meal, symptom promptly has alleviation after 1 month, take 3 months after, symptom is obviously improved.17 philtrums of clinical experiment, produce effects 8 people, effective 8 people, invalid 1 people, total effective rate 94.4%.

Claims (1)

1. a Chinese medicine for the treatment of chronic hepatitis adopts the raw material of Chinese medicine preparation, and weight ratio is:
Rhizoma Polygoni Cuspidati 4---15 parts of 30 portions of Radix Notoginseng 3---20 portions of Ganodermas 2---
PINGDIMU 4---30 parts of 30 portions of Herba Sedis 5---40 parts of Rhizoma Smilacis Glabraes 4---
30 parts of Radix Angelicae Sinensis 4---30 parts of Radix Rehmanniae 4---
The Chinese medicine of this treatment chronic hepatitis is made by following method:
(1) by above-mentioned weight ratio, Rhizoma Polygoni Cuspidati, PINGDIMU, Herba Sedi, Rhizoma Smilacis Glabrae, Radix Angelicae Sinensis, the Radix Rehmanniae are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Radix Notoginseng, Ganoderma are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; As required, make Chinese medicine granules, powder, capsule, watered pill, Tabules.
CN2009102371062A 2009-11-04 2009-11-04 Chinese medicament for treating chronic hepatitis Expired - Fee Related CN101843817B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2009102371062A CN101843817B (en) 2009-11-04 2009-11-04 Chinese medicament for treating chronic hepatitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2009102371062A CN101843817B (en) 2009-11-04 2009-11-04 Chinese medicament for treating chronic hepatitis

Publications (2)

Publication Number Publication Date
CN101843817A CN101843817A (en) 2010-09-29
CN101843817B true CN101843817B (en) 2011-08-10

Family

ID=42768755

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2009102371062A Expired - Fee Related CN101843817B (en) 2009-11-04 2009-11-04 Chinese medicament for treating chronic hepatitis

Country Status (1)

Country Link
CN (1) CN101843817B (en)

Also Published As

Publication number Publication date
CN101843817A (en) 2010-09-29

Similar Documents

Publication Publication Date Title
CN101843787B (en) Chinese medicament for treating benign prostatic hyperplasiabrain
CN101843694B (en) Chinese medicament for treating chronic hepatitis
CN101850071B (en) Chinese medicament for treating chronic nephritis
CN101843704B (en) Chinese medicament for treating chronic hepatitis
CN101843709B (en) Chinese medicament for treating abnormal menstruation
CN101850046B (en) Chinese medicament for treating chronic hepatitis
CN101843707B (en) Chinese medicament for treating chronic hepatitis
CN101843726B (en) Chinese medicament for treating chronic hepatitis
CN101843817B (en) Chinese medicament for treating chronic hepatitis
CN101843775A (en) Chinese medicament for treating diabetic nephropathy
CN101843745B (en) Chinese medicament for treating chronic hepatitis
CN101884747B (en) Traditional Chinese medicine for treating chronic nephritis
CN101843705B (en) Chinese medicament for treating lupus erythematosus
CN101843693A (en) Chinese medicament for treating diabetic nephropathy
CN101843803A (en) Chinese medicament for treating diabetic nephropathy
CN101874870B (en) Traditional Chinese medicine for treating chronic hepatitis
CN101843818B (en) Chinese medicament for treating chronic nephritis
CN101843816B (en) Chinese medicament for treating chronic nephritis
CN101843777B (en) Chinese medicament for treating liver cirrhosis
CN101843826B (en) Chinese medicament for treating chronic kidney failure
CN101843831B (en) Chinese medicament for treating diabetic cardiopathy
CN101843808B (en) Chinese medicament for treating ichthyosis
CN101843833B (en) Chinese medicament for treating diabetic nephropathy
CN101843750B (en) Chinese medicament for treating chronic nephritis
CN101843756B (en) Chinese medicament for treating chronic nephritis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: RUGAO RICH STEEL MACHINERY PARTS CO., LTD.

Free format text: FORMER OWNER: BEIJING LVYUANQIUZHENG TECHNOLOGY DEVELOPMENT CO., LTD.

Effective date: 20130710

C41 Transfer of patent application or patent right or utility model
COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 100040 SHIJINGSHAN, BEIJING TO: 226500 NANTONG, JIANGSU PROVINCE

TR01 Transfer of patent right

Effective date of registration: 20130710

Address after: 226500, Jiangsu, Rugao moved by the town, moved through the village of twenty-four groups

Patentee after: Rugao Fu Steel Machinery Fittings Co., Ltd.

Address before: 100040 Beijing city Shijingshan District street Babaoshan Lugu Village District No. 7 building 10-602 room

Patentee before: Beijing Lvyuanqiuzheng Technology Development Co., Ltd.

CB03 Change of inventor or designer information

Inventor after: An Xiaoling

Inventor before: Liu Xinzhuang

CB03 Change of inventor or designer information
TR01 Transfer of patent right

Effective date of registration: 20171228

Address after: Changning Street Ningjiang district 138000 of Jilin province Songyuan Municipal Committee of 7

Patentee after: An Xiaoling

Address before: 226500, Jiangsu, Rugao moved by the town, moved through the village of twenty-four groups

Patentee before: Rugao Fu Steel Machinery Fittings Co., Ltd.

TR01 Transfer of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20110810

Termination date: 20181104

CF01 Termination of patent right due to non-payment of annual fee